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ABSTRACT
There is a great need to develop methods to regulate cellular growth in order to enhance
or prevent cell proliferation, as needed, to either improve health or prevent disease. In this work
we evaluated the adhesion, survival and growth of bone marrow stromal cells on the surface of
several new ion beam engineered nano-crystals of ceramic hard coatings such as zirconium,
titanium, tantalum and cerium oxides. Cell adhesion and growth on the ceramic coatings were
compared to adhesion and growth on a nano-crystalline silver coating which is known to possess
antibacterial properties. The initial results of a study to determine the effect of nanocrystalline
titanium and silver coating on staphylococcus aureus biofilm growth is also discussed.
INTRODUCTION
Joint replacement for arthritic joints is a successful procedure to relieve pain and increase
function. For example, in 2005 over 249,000 Americans underwent hip replacement and 488,000
had knee replacements [1]. Shoulders, wrists, and even spinal discs are also being replaced more
frequently than ever before. And in the future, we will see a massive increase in all of these joint
replacements as the 37 million baby boomers age. Kurtz et al [1] predict that by 2010 hip and
knee replacements will number over one million and by 2030 we will see 4.5 million annually.
This is an increase of over 400 percent from the present figures.
Most artificial prostheses employ a combination of titanium or cobalt-chrome metallic
components combined with various types of plastic. There have been dramatic improvements in
the quality and lifespan of such implants with a corresponding decreased incidence of
complications. Typically, in regards to orthopedic devices, the primary concerns are wear [2]
infection [3,4], and failure of biointegration [5,6]. Wear of the plastic component produces micro
particles that cause an immunological response and adjacent bone resorption [2]. Infection,
although less common, is devastating to the patient and costly to the health care system [3,4].
Failure of osseointegration of the prosthesis prevents long-term stability which contributes to
pain [6], implant loosening [6], and infection [5] that usually necessitates revision. To prevent
these complications, prostheses of the future must optimize the material composition of
components.

Optimal component materials will be wear resistant, bactericidal, and encourage
biointegration. Specifically, the surface/surface components of the implant should resist wear
and especially should resist the generation of particulates as a consequence of wear-induced
degeneration. The surface should also be anti-infective through surface morphology or
chemistry. For example, silver is known to have broad spectrum antibiotic properties [5].
However to date, the release of the silver cannot be controlled. Finally, the bone contacting
surface of the implant should interact positively with mesenchymal stromal cells (MSC) and
their pre-osteoblast progeny to promote and maintain osseointegration. This biocompatible
surface will lead to tissue integration and vascularization, which will prevent bacterial adhesion
and biofilm formation [5]. If possible, the surface should also be designed to be “smart” and
boost its anti-infective properties in response to the presence of infectious agents.
We have initiated programs to address the challenge of devising and developing implants with a
“triple smart” surface. Ideally, a smart implant will optimize resistance to wear of articulating
surfaces of artificial orthopaedic implants, will combine osseointegrative properties in areas
where bone is in contact with the implant, and will prevent bacterial biofilm formation. We
believe the development of a smart coating to prevent biofilm formation while promoting
adhesion and growth of stem cells is of great importance to the longevity of orthopaedic
arthroplasty implants and internal and external orthopaedic fixation devices. In this paper, we
report preliminary results of the adhesion, survival and growth of bone marrow stromal cells on
several ultrahydrophilic nano-crystal film surface coatings. We also report on staphylococcus
aureus growth on titanium and silver nano-crystal surface coatings.
EXPERIMENTAL PROCEDURES
Nanocrystalline films
Fabricating biocompatible surfaces with a well defined nanostructure and morphology by
conventional techniques is very difficult. However, ion beam assisted deposition (IBAD) can
provide the possibilities of designing and engineering nanocrystalline coatings with well defined
structures, chemistry and morphology. The IBAD combines physical vapor deposition with
concurrent ion beam bombardment (e.g. N, O, and Ar) in a high vacuum environment (figure
1a). All nanocrystalline samples reported here were deposited in a 41”x45”x37” (2” thick)
stainless steel water cooled ultralow vacuum chamber (10-8 torr), (figure 1b). The IBAD system
is comprised of a RF Ion Gun that supplies ions at energies up to 1500 eV, a DC ion Gun with an
ion density of 3A at energies up to 150 eV, a thermal evaporation source, and a 10 kW electron
gun with a programmable sweep multi pocket four electron beam evaporation source. Energetic
ions (ionic hammers) are employed to produce “engineered nano-crystals” with superior
properties (hardness and wettability) that are then “stitched” to any substrate by ion
bombardment. Furthermore, IBAD is applied to produce materials with exceptional chemical,
physical, mechanical and nano-structural properties that nature does not allow to occur in
equilibrium conditions.

Figure 1 a) Ion Beam Assisted Deposition System b) Schematic of twin IBAD process. The
process combines physical vapor deposition (evaporation) with concurrent ion bombardment to
produce a wide range of smart coatings with exceptional adhesion to virtually any substrate.
Cloned bone marrow stromal cell line
The stromal cells, OMA-AD, are utilized to determine the effect of nanostructure
coatings and their material composition on cell growth. These cells were derived from the bone
marrow of a female C57Bl/6 mouse by repeated trypsinization of the adherent layer of a longterm bone marrow culture. The cell line was cloned by limiting dilution plating and was
expanded in Fischer’s medium containing 10% fetal bovine serum (FBS), 10% horse serum
(HS), 2 mM L-glutamine and 1x10-6 M hydrocortisone. The morphology of the cells shows a
wide spread cytoplasm similar to a blanket cell [7]. OMA-AD supports the maintenance of
primitive mouse hematopoietic stem cells [8] and human hematopoietic cells [9].
OMA-AD cells were cultured at 37°C in a humidified incubator containing 5% CO2 in air
for up to 12 days. The growth medium was RPMI 1640 medium, 10% fetal bovine serum (FBS),
10% horse serum (HS), 100 units/ml penicillin, 100 µg/ml streptomycin, 2 mM L-glutamine and
1x10-6 hydrocortisone. Alamar Blue assay [10] and direct cell counting methods were used to
determine the growth of OMA-AD on the different nanoengineered surfaces.
Biofilm assays
Staphylococcus aureus biofilm was grown on either elemental nanocrystalline titanium or
silver which was deposited into silicon substrates in a BST FC 270 Flow Cell apparatus from
BioSurface Technologies, Corp. (Bozeman, MT) as follows. Six-hour trypticase soy broth (TSB)
cultures of S. aureus strain 15981 were diluted in 3 ml of TSB to an OD600 = 0.05 and were used
to inoculate the flow cell chambers, whose setup was performed according to the manufacturer’s
recommendations. Before inoculation, culture media (0.1×TSB + 0.25% glucose) was pumped
through the flow cells at a rate of 0.75 ml⋅min-1 for 1 hour. After inoculation, the flow cell
reactor was incubated statically for 120 minutes at 37°C, and then the media flow was resumed.
After incubation, for 24 hours at 37°C, the media flow was stopped and the bacterial growth on
each chip was washed three times with 1.0 ml of PBS buffer. The bacterial growth was then
scraped from the surface and the viable cells remaining were quantified using standard dilution
plating techniques.

EXPERIMENTAL RESULTS
In vivo, much of the proliferative activity in bone cell development is associated with
mesenchymal precursors. However, in vitro, osteoblast cell lines often have characteristics
resembling tumor cancer cells, including dysregulated cell proliferation. Consequently, their
growth on surface coatings may not be typical of normal cells. Because of these concerns over
the use of osteoblast cell lines, the current studies were performed using a cloned bone marrow
stromal cell line from C57Bl mice termed OMA-AD cells. This is a spontaneously immortalized
undifferentiated stromal cell population that resembles multipotential mesenchymal stromal cells
(MMSC). OMA-AD cell line duplicates, in vitro, all of the characteristics of primary
mesenchymal stem cells and is a valid experimental model to probe the impact of nanocrystalline
hard ceramic coatings on the attachment, survival and growth of bone marrow stromal cells.
The engineered nanocrystalline metal, such as titanium and silver, and transparent
ceramic films deposited on silicon, quartz, and glass substrates were placed in wells of culture
plate containing specifically formulated growth medium. Depending on the experiments, defined
numbers of OMA-AD cells were added to each well and the plates were cultured. Figure 2a
shows Alamar blue assay results for growth of OMA-AD on a nanostructure of ZrO2 (with a zero
contact angle and a total wettability to water), Ta2O5, TiN, and on two different silver (Ag)
coatings deposited under different IBAD deposition conditions. As shown here, cubic zirconia
supported the highest cell growth and silver supported the lowest OMA-AD growth. Figure 2b
shows growth of cloned bone marrow stromal cells, OMA-AD, on transparent tantalum oxide
deposited on quartz substrate.

(a)
(b)
Figure 2a Growth of OMA-AD (as determined by Alamar Blue Assay) on nanocrystalline
coatings of cubic zirconium, tantalum oxide, titanium nitrite, and two nanocrystalline silver
coatings produced by two different IBAD processes. 2b Typical morphological appearance of
OMA-AD grown on transparent Ta2O5 deposited on quartz substrate.
Figure 3a shows the growth of OMA-AD on nanocrystalline titanium and silver. Silver
demonstrated the least support of OMA-AD when compared to titanium and ceramics (see also
figure 2a). Silver consistently suppresses the growth of bone marrow stromal cells. Figure 3b
shows an atomic force microscopy (AFM) image of nanocrystalline titanium with a roughness of

16 nm, and figure 3c shows an AFM image of nanocrystals of silver with a roughness of 116 nm.
Both of these nanocrystalline coatings were deposited by IBAD using Argon bombardment.
To assess the impact of the nanocrystalline coatings on the growth of bacterial biofilm,
we performed continuous flow biofilm assays using a common nosocomial pathogen,
Staphylococcus aureus. Samples were placed in a flow cell chamber and inoculated with S.
aureus strain 15981 and grown for 24 hours. The total number of viable cells (see figure 4a)
remaining after washing the samples was reduced on the nanocrystalline silver deposited silicon
(3.58 ± 0.78 × 108) compared to those that were deposited with nanocrystalline titanium (1.19 ±
0.29 × 109). These initial results suggest that nanocrystalline silver deposited with argon
bombardment reduces bacterial viability, which is consistent with OMA-AD results.
Figure 4b and 4c show the contact angle of IBAD fabricated nanocrystals of titanium and
sliver deposited on semiconductor grades of silicon substrates. The titanium nanocrystal sample
has a roughness of about 16 nm (figure 3b), with a fine nanocrystal grain, and a contact angle of
about 4 degrees. Even though the top few atomic layers of titanium nanocrystals are oxidized in
air (even for the samples that are deposited in an ultra high vacuum system), our results
suggested that they are less supportive of OMA-AD growth than the IBAD produced
nanocrystals of TiO2 with anatase crystal structure. The silver nanocrystal sample has a
roughness of about 116 nm (figure 3c) and a contact angle close to 90 degrees; while the contact
angles of orthopaedic grade materials measured in the range of around 60 degrees. Lower
contact angle translates to wettability to water and can be explained by the Wenzel model [11] of
increase of actual surface to apparent surface area. Increased wettability (hydrophilicity) may
encourage cell adhesion and growth as seen with the OMA-AD, and encourage biofilm growth
as see on the nanocrystalline Ti (figure 4a). While large contact angles that have decreased
wettability (hydrophobia), as seen with nanocrystalline Ag, have been found to support only
minimal cell growth (figure 2a & 4a). In principal, one can apply (as we have done here) the
Wenzel model and design surface coatings to amplify hydrophilic or hydrophobic properties.

Figure 3 a) Comparison of OMA-AD growth on nanocrystalline Ti to growth on nanocrystalline
Ag. (b) and (c) surface morphology and roughness for nanocrystalline Ti and Ag respectively.

Figure 4 a) Comparison of staphylococcus aureus growth on nanocrystalline Ti to growth on
nanocrystalline Ag, (b) Contact angle for nanocrystal coating of Ti, indicating it has total
wettability to water and thus possesses hydrophilic properties (c) Nanocrystal coating of silver
with hydrophobic properties (d) Orthopaedic Ti component.
DISCUSSION AND CONCLUSIONS
Nanostructured substrates exhibited differences in their ability to support the growth of
OMA-AD cells. Nanostructurally stabilized cubic zirconia and tantalum oxide exhibited the
highest support of the OMA-AD cells, while Ag showed the least support. Our data indicates that
nanostructures and chemical properties of surfaces both influence the attachment and growth of
OMA-AD. Furthermore, our preliminary results showed reduced staphylococcus aureus
attachment and growth on sliver nanostructures. However at this time, the impact of the
hydrophobic characteristic of nanocrystalline silver on attachment and growth of OMA-AD cells
and bacteria is not clear and therefore warrants further studies.
Hydroxyapatite (HA) has been studied for decades because of their bioactive properties
“as they bond to bone and enhance bone tissue formation” [12]. However, concerns have been
raised about the bioabsorption of the HA layer, the mechanical strength of the HA layer [12, 13]
and the HA layer debonding from the metal implant [13,14]. It is possible that our
nanostructured substrates may address the concerns with HA. First, it appears that the high
wettability of our zirconium and tantalum oxides may play an important role in osteointegration
of artificial implants. Then these ceramics are attractive not only because of the possibility of
their osteoconductivity properties, but also because of their mechanical strength and the
possibility of their excellent adhesion to metallic components because of the IBAD process.
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